Choi, Seunghyuk
Zhang, Bing
Funding for this research was provided by:
Ministry of Science and ICT, South Korea (No.RS-2025-02219317)
Cancer Prevention and Research Institute of Texas (RP240137)
National Cancer Institute (U24 CA271076)
Article History
Received: 15 July 2025
Accepted: 17 December 2025
First Online: 23 December 2025
Declarations
:
: Not applicable.
: Not applicable.
: B.Z. received research funding from AstraZeneca and consulting fees from Inotiv. S.H.C. declares no competing interests.